Dr. John Mayfield is chief business officer at Be Biopharma, leveraging his expertise in licensing, transactions, and establishing strategic collaborations within the biotechnology and pharmaceutical industries, driving Be Bio towards its goal to fully unleash the power of B cell medicines.
Dr. Mayfield previously held roles at EQRx where he was most recently the vice president of Corporate and Business Development. At EQRx, he led a team that executed significant deal-flow spanning co-development and co-commercialization partnerships to licensing and collaboration agreements for preclinical, clinical and commercial-stage medicines. He was director of business development at Voyager Therapeutics where he helped build strategic partnerships to advance Voyager’s gene therapy programs and provide capital to reach corporate objectives.
Prior to that, he served as associate director of business and corporate development at Foundation Medicine where he built global biotech and pharma partnerships to integrate the company’s testing within clinical trials. Prior to working in business development, John held roles in development and operations at Foundation Medicine and Illumina.
“The journey from scientist to biotech executive has been one of the most rewarding in my career, and I am thrilled to return to my alma mater to not only help researchers navigate the process of bringing life-saving and world-changing technologies to market but to also help foster their entrepreneurial spirit and talent,” says Dr. Mayfield. “At the end of the day, for me, it’s about helping people.”
Dr. Mayfield earned his Ph.D. in the plant molecular and cellular biology program in the laboratory of Dr. Robert Ferl at University of Florida in 2007, followed by postdoctoral research appointments in breast cancer biology at Washington University in St. Louis and genomics at Duke University’s Institute of Genome Science and Policy. In 2012, he founded Triangle Biotech Tuesday, a biotechnology networking and industry advocacy group in North Carolina’s Research Triangle that continues to grow and hold monthly events.